Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1116136-63-0 | MDL No. : | MFCD16876018 |
Formula : | C7H4ClN3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZVKDTXRWTRDHMC-UHFFFAOYSA-N |
M.W : | 197.58 | Pubchem ID : | 57613574 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 49.93 |
TPSA : | 74.5 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.18 cm/s |
Log Po/w (iLOGP) : | 0.83 |
Log Po/w (XLOGP3) : | 1.86 |
Log Po/w (WLOGP) : | 2.12 |
Log Po/w (MLOGP) : | 0.9 |
Log Po/w (SILICOS-IT) : | 0.48 |
Consensus Log Po/w : | 1.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.68 |
Solubility : | 0.41 mg/ml ; 0.00207 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.05 |
Solubility : | 0.178 mg/ml ; 0.0009 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.91 |
Solubility : | 0.242 mg/ml ; 0.00122 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 3.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.07 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280 | UN#: | N/A |
Hazard Statements: | H302-H317 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Into a 250 ml 3-necked roundbottom flask, was placed a solution of 5-chloro-3-nitro-1H- pyrrolo[3,2-b]pyridine (1.1 g, 5.56 mmol, 1.00 equiv) in 1,4-dioxane (30 ml). To this was added HCl (6mol/L) (15 ml, 90 mmol, 16.00 equiv). This was followed by the addition of a solution of Fe (2.5 g, 44.64 mmol, 8.00 equiv) in MeOH (50 ml). The resulting solution was allowed to react, with stirring, for 3 hours while the temperature was maintained at reflux in a bath of oil. A filtration was performed. The filtrate was concentrated by evaporation under vacuum using a rotary evaporator. The resulting solution was diluted with H2O. Adjustment of the pH to 7-8 was accomplished by the addition of Na2CO3. The resulting solution was extracted three times with 100 ml of EtOAc and the organic layers combined and dried over Na2SO4 and concentrated by evaporation under vacuum using a rotary evaporator. This resulted in 1.3 g (crude) of 5-chloro-1H-pyrrolo[3,2-b]pyridin-3-amine as a black solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
3.1 g | With sulfuric acid; potassium nitrate at 0 - 20℃; for 2h; | 1 Step 1: 5-chloro-3-nitro-1H-pyrrolo [3,2-b pyridine 5-Chloro- 1H-pyrrolo[3,2-b]pyridine (3.0 g, 19.7 mmol, 1.0 equiv.) was dissolved in concentrated H2SO4 (5 mL) and cooled to 0 °C, then KNO3 (2.4 g, 23.8 mmol, 1.2 equiv.) was added in portions, maintaining the solution at 0 °C. The reaction mixture was stirred for 2 hours at ambient temperature and then quenched by the addition of water. The resulting solution was adjusted to pH 9 with saturated aqueous NaHCO3. The resulting mixture was extracted with ethyl acetate, washed with brine, dried over anhydrous Na2SO4 and concentrated under vacuum to 5-chloro-3-nitro- l H-pyrrolo[3,2-b]pyridine (3.1 g) as a yellow solid. LCMS Method BA: [M+H]+ = 198. |
[ 65156-94-7 ]
5-Chloro-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.77
[ 26820-34-8 ]
2-Chloro-6-methyl-5-nitronicotinonitrile
Similarity: 0.75
[ 93683-65-9 ]
6-Chloro-3-nitropicolinonitrile
Similarity: 0.74
[ 22280-56-4 ]
2-Chloro-3-methyl-5-nitropyridine
Similarity: 0.74
[ 26820-34-8 ]
2-Chloro-6-methyl-5-nitronicotinonitrile
Similarity: 0.75
[ 93683-65-9 ]
6-Chloro-3-nitropicolinonitrile
Similarity: 0.74
[ 22280-56-4 ]
2-Chloro-3-methyl-5-nitropyridine
Similarity: 0.74
[ 67058-77-9 ]
3-Nitro-1H-pyrrolo[2,3-c]pyridine
Similarity: 0.68
[ 65156-94-7 ]
5-Chloro-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.77
[ 67058-77-9 ]
3-Nitro-1H-pyrrolo[2,3-c]pyridine
Similarity: 0.68
[ 1190310-75-8 ]
3-Bromo-5-chloro-1H-pyrrolo[3,2-b]pyridine
Similarity: 0.66
[ 800401-62-1 ]
Ethyl 5-chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylate
Similarity: 0.64
[ 1354542-05-4 ]
3-Nitro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride
Similarity: 0.64